Efficacy and Safety of Using Tranexamic Acid in Articular Cavity to Decrease Blood Loss after Total Knee Arthroplasty

张权,孙立,杨先腾,汪健,田晓滨,方开云,刚绍鹏
DOI: https://doi.org/10.3760/cma.j.issn.1671-7600.2015.05.006
2015-01-01
Abstract:Objective To investigate the efficacy and safety of using tranexamic acid in articular cavity to decrease blood loss after total knee arthroplasty (TKA).Methods From June 2013 to May 2014,60 patients receiving TKA were divided into 2 even groups (n=30).In observation group,1g tranexamic acid in 20 mL physiological saline was injected into the articular cavity of each patient after the joint capsules were sutured.Meanwhile,30 patients in the control group received injection of only 20 mL physiological saline.After TKA,closed drainage was carried out for 3 hours.The 2 groups were observed and compared in terms of hemoglobin at 6 h,24 h and 72 h postoperation,activated partial thromboplastin time (APTT),fibrinogen (FIB),prothrombin time (PT),drainage volume at 24 h postoperation,hidden blood loss,total blood loss,and transfusion rate.Meanwhile,both groups were observed for incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE).Results The 2 groups obtained an average follow-up of 9.9 months (from 6 to 17 months).The decreases in hemoglobin at 6 h,24 h and 72 h postoperation in the observation group (0.09% ±0.06%,0.16% ±0.06% and 0.25% ±0.05%) were significantly lower than those in the control group (0.12% ±0.06%,0.23% ±0.05% and 0.34% ±0.05%);the drainage volume at 24h postoperation (216.97 ± 101.39 mL),hidden blood loss (566.84 ± 258.68 mL),and total blood loss (909.36 ±267.43 mL) in the former were also significantly lower than in the latter (598.40 ± 104.15 mL,671.71 ± 319.55 mL and 1,189.72 ± 306.99 mL respectively) (P < 0.05).There were no significant between-group differences in FIB,PT,APTT or transfusion rate (P > 0.05).No DVT or PE was observed in the follow-ups in either group.Conclusion Use of tranexamic acid in the articular cavity for patients after TKA can significantly decrease blood loss and blood transfusion rate,increasing no risk of DVT and PE.
What problem does this paper attempt to address?